View in EDS PDF Full Text

Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB.

Saved in:
Bibliographic Details
Title: Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB.
Authors: Murray MH; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA., Valfort AC; University of Florida Genetics Institute, Gainesville, FL, 32610, USA., Koelblen T; University of Florida Genetics Institute, Gainesville, FL, 32610, USA., Ronin C; NovAliX SAS, Strasbourg, France., Ciesielski F; NovAliX SAS, Strasbourg, France., Chatterjee A; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA., Veerakanellore GB; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA., Elgendy B; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA., Walker JK; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA., Hegazy L; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA. Lamees.Hegazy@uhsp.edu.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA. Lamees.Hegazy@uhsp.edu., Burris TP; University of Florida Genetics Institute, Gainesville, FL, 32610, USA. burris.thomas@ufl.edu.
Source: Nature communications [Nat Commun] 2022 Nov 21; Vol. 13 (1), pp. 7131. Date of Electronic Publication: 2022 Nov 21.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36414641
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Murray+MH%22">Murray MH</searchLink>; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Valfort+AC%22">Valfort AC</searchLink>; University of Florida Genetics Institute, Gainesville, FL, 32610, USA.<br /><searchLink fieldCode="AU" term="%22Koelblen+T%22">Koelblen T</searchLink>; University of Florida Genetics Institute, Gainesville, FL, 32610, USA.<br /><searchLink fieldCode="AU" term="%22Ronin+C%22">Ronin C</searchLink>; NovAliX SAS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Ciesielski+F%22">Ciesielski F</searchLink>; NovAliX SAS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Chatterjee+A%22">Chatterjee A</searchLink>; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.<br /><searchLink fieldCode="AU" term="%22Veerakanellore+GB%22">Veerakanellore GB</searchLink>; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Elgendy+B%22">Elgendy B</searchLink>; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Walker+JK%22">Walker JK</searchLink>; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.<br /><searchLink fieldCode="AU" term="%22Hegazy+L%22">Hegazy L</searchLink>; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA. Lamees.Hegazy@uhsp.edu.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA. Lamees.Hegazy@uhsp.edu.<br /><searchLink fieldCode="AU" term="%22Burris+TP%22">Burris TP</searchLink>; University of Florida Genetics Institute, Gainesville, FL, 32610, USA. burris.thomas@ufl.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2022 Nov 21; Vol. 13 (1), pp. 7131. <i>Date of Electronic Publication: </i>2022 Nov 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36414641
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-022-34892-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7131
    Titles:
      – TitleFull: Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Murray MH
      – PersonEntity:
          Name:
            NameFull: Valfort AC
      – PersonEntity:
          Name:
            NameFull: Koelblen T
      – PersonEntity:
          Name:
            NameFull: Ronin C
      – PersonEntity:
          Name:
            NameFull: Ciesielski F
      – PersonEntity:
          Name:
            NameFull: Chatterjee A
      – PersonEntity:
          Name:
            NameFull: Veerakanellore GB
      – PersonEntity:
          Name:
            NameFull: Elgendy B
      – PersonEntity:
          Name:
            NameFull: Walker JK
      – PersonEntity:
          Name:
            NameFull: Hegazy L
      – PersonEntity:
          Name:
            NameFull: Burris TP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 11
              Text: 2022 Nov 21
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1